Orexigen Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
18.89 M |
Public Float |
8.37 M |
Address |
3344 North Torrey Pines Court La Jolla California 92037 United States |
Employees | - |
Website | http://www.orexigen.com |
Updated | 09/14/2018 |
Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. |